关于我们
—
关于我们
—
Ampeptec是一家从事化学合成多肽创新药的制药公司，专门开发长效的多肽药物用于改善患者的依从性，提高患者的生活质量。
创新药GLP-1受体激动剂APT3711，用于体重控制和2型糖尿病的治疗，只需要每月注射1次或每周口服1次。APT3711半衰期是司美格鲁肽的2倍。我们相信，与当前每周注射一次和一天口服一次的药物和其他在研的 GLP-1 候选药物相比，APT3711将成为体重控制和2型糖尿病治疗的同类最佳药物。
创新药APT3598是一种一周注射1次的治疗糖尿病药物。在相比诺和诺德的依柯胰岛素能更加稳定的控制血糖，且持续时间更长。APT3598是全球第一个化学合成的胰岛素类似物，可以更好地改善糖尿病患者的生活质量。
Ampeptec是一家从事化学合成多肽创新药的制药公司，专门开发长效的多肽药物用于改善患者的依从性，提高患者的生活质量。
创新药GLP-1受体激动剂APT3711，用于体重控制和2型糖尿病的治疗，只需要每月注射1次或每周口服1次。APT3711半衰期是司美格鲁肽的2倍。我们相信，与当前每周注射一次和一天口服一次的药物和其他在研的 GLP-1 候选药物相比，APT3711将成为体重控制和2型糖尿病治疗的同类最佳药物。
创新药APT3598是一种一周注射1次的治疗糖尿病药物。在相比诺和诺德的依柯胰岛素能更加稳定的控制血糖，且持续时间更长。APT3598是全球第一个化学合成的胰岛素类似物，可以更好地改善糖尿病患者的生活质量。
产品管线
—
产品管线
—
新闻
—
Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh's preclinical drug
As well as the upfront cash, Merck & Co. is eligible to pay Hansoh Pharma up to $1.9 billion in milestone payments for the exclusive global license to the HS-10535. (Merck & Co.)
Diabetes Drug Market Size to Attain Around USD 132.36 Billion by 2034
The global diabetes drug market size was evaluated at USD 66 billion in 2023 and
Why the anti-obesity drug market could grow to $100 billion by 2030
Earlier this year, the global market for anti-obesity medications (AOMs) reached $6 billion on an annualized basis. By 2030, it could grow by more than 16 times to $100 billion, according to Goldman Sachs Research.
新闻
—
Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh's preclinical drug
As well as the upfront cash, Merck & Co. is eligible to pay Hansoh Pharma up to $1.9 billion in milestone payments for the exclusive global license to the HS-10535. (Merck & Co.)
Diabetes Drug Market Size to Attain Around USD 132.36 Billion by 2034
The global diabetes drug market size was evaluated at USD 66 billion in 2023 and
Why the anti-obesity drug market could grow to $100 billion by 2030
Earlier this year, the global market for anti-obesity medications (AOMs) reached $6 billion on an annualized basis. By 2030, it could grow by more than 16 times to $100 billion, according to Goldman Sachs Research.
Ampeptec, Inc.
442 Park West Drive
Grovetown, GA 30813
E-mail: info@ampeptec.com
投资者
Simrat Singh
首席运营官
E-mail: simrat.singh@ampeptec.com
招贤纳士
Jackie Gay
人力资源经理
E-mail: jackie.gay@ampeptec.com
English
客服1
客服2